Cardiomyopathie door mutatie in het phospholamban-gen: Een genetische afwijking met veel impact

Translated title of the contribution: Cardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality

Peter van der Meer, Eva van Rooij, Pieter A. Doevendans

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A mutation in the Phospholamban gene where the Arginine at position 14 (PLN-R14Del) is missing is causing a severe cardiomyopathy often leading to cardiac transplantation in the Netherlands. We estimated that approximately 25% of all transplanted patients carry this mutation. The origin is dated somewhere around the year 1300 in the north of country. Currently we have identified 1600 carriers with the identical mutation. We are in the process of developing and applying gene therapy to come to a specific treatment for the 700 carriers with symptoms we see today.

Translated title of the contributionCardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality
Original languageDutch
Article numberD7274
JournalNederlands Tijdschrift voor Geneeskunde
Volume167
Publication statusPublished - 19 Apr 2023

Fingerprint

Dive into the research topics of 'Cardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality'. Together they form a unique fingerprint.

Cite this